Results 1 to 10 of about 32,203 (276)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer

open access: goldCancer Management and Research, 2021
Jiejie Hu, Xianghou Xia, Hongjian Yang, Yang Yu Breast Surgery Department, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou ...
Hu J, Xia X, Yang H, Yu Y
doaj   +6 more sources

Axillary lymph node dissection: Dead or still alive? [PDF]

open access: yesBreast, 2023
Although sentinel lymph node biopsy is now the primary method of axillary staging and is therapeutic for patients with limited nodal disease, axillary lymph node dissection (ALND) is still necessary for staging in groups where sentinel lymph node biopsy ...
Anna C. Beck, Monica Morrow
doaj   +4 more sources

Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance

open access: goldBreast Cancer: Targets and Therapy, 2012
Daigo Yamamoto,1 Kanji Tanaka,2 Yu T subota,1 Noriko Sueoka,1 Tetsuji Shoji,3 Kayoko Kuwana,1 A-Hon Kwon11Department of Surgery, Kansai Medical University, Hirakata, 2Ribon-Rose Tanaka Kanji Breast Clinic, 3Shoji Clinic, Osaka, JapanBackground: Sentinel ...
Yamamoto D   +6 more
doaj   +3 more sources

Recent advances and perspectives in the application of repeat sentinel lymph node biopsy in breast cancer patients underwent breast-conserving surgery [PDF]

open access: yesZhongguo aizheng zazhi, 2023
Due to a series of complications associated with traditional axillary lymph node dissection, sentinel lymph node biopsy has now replaced axillary lymph node dissection as the standard axillary staging procedure for patients with negative axillary lymph ...
ZHAO Qian, LING Yunxiao, LIU Guangyu
doaj   +1 more source

Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment [PDF]

open access: yes, 2023
Background: The initial results of the SINODAR-ONE randomized clinical trial reported that patients with T1-2 breast cancer and one to two macrometastatic sentinel lymph nodes treated with breast-conserving surgery, sentinel lymph node biopsy only, and ...
Barbieri E.   +62 more
core   +1 more source

Concordance between Axillary Ultrasound and Sentinel Biopsy in Clinically Node-Negative Early Breast Cancer

open access: yesPakistan Armed Forces Medical Journal, 2023
Objective: To determine the sensitivity of axillary ultrasound in detecting axillary nodal metastasis in clinically and radiologically uninvolved axillary nodes in early carcinoma breast by comparing with sentinel node biopsy histopathology on frozen ...
Afroz Mushtaq   +7 more
doaj   +1 more source

Ultrasonography for Staging Axillary Lymph Node in Breast Cancer Patients

open access: yesJournal of Surgical Ultrasound, 2020
The identification of axillary lymph node metastases in breast cancer patients is a critical factor in determining the stage, deciding the treatment modality, and predicting the prognosis.
Hyun Jo Youn   +3 more
doaj   +1 more source

Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes. [PDF]

open access: yesPLoS ONE, 2013
To determine the performance of intraoperative one-step nucleic acid amplification (OSNA) assay in detecting sentinel lymph node metastases compared to postoperative histology taking into account breast cancer molecular classification and to evaluate ...
Simonetta Buglioni   +11 more
doaj   +1 more source

NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy

open access: yesContemporary Clinical Trials Communications, 2020
Sentinel lymph node biopsy alone, without complete axillary lymph node dissection, is the standard treatment of the axilla nodal chain in early-stage breast cancer patients presenting a negative sentinel lymph node. The updated results of the IBCSG 23-01
Corrado Tinterri   +3 more
doaj   +1 more source

A prospective audit to assess the feasibility of sentinel lymph node biopsy and/or low axillary sampling in clinicoradiologically node-negative axilla for early breast carcinoma

open access: yesAsian Journal of Medical Sciences, 2023
Background: Sentinel lymph node (SLN) dissection was designed to minimize side effects of lymph node surgery but still offer outcomes of axillary lymph node dissection.
Abasaheb Madhukar Tidake   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy